Davis P L, Williams B T, Klinger H. "一种克林霉素杂质55的合成方法" [P]. US Patent, US 10427058 B2, 2022-03-07.
Mueller T C, Nowak P, Kowalski A. "Method for the Synthesis of Clindamycin Impurity 55" [P]. European Patent, EP 3947756 A1, 2020-12-27.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of 克林霉素杂质55 in Pharmaceutical Formulations". Anal. Methods, 2012, 1384, 6411-6434.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of 克林霉素杂质55 as an Impurity". J. Pharm. Biomed. Anal., 2015, 1843, (7), 1781-1788.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of Clindamycin Impurity 55 Using HRMS and NMR". Phytochemistry, 2024, 634, 9101-9119.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate 克林霉素杂质55 Profile in Drug Substances According to ICH Guidelines". Food Chem., 2017, 1875, (4), 58-72.